The tryptophan utilization concept in pregnancy

키워드

참고문헌 (75)

1. Bender DA, "Biochemistry of tryptophan in health and disease", Mol Aspects Med, 6, pp.101~197 (1983)
2. Badawy AA, "Tryptophan metabolism in alcoholism", Nutr Res Rev, 15, pp.123~152 (2002)
3. Badawy AA, "Effects of pregnancy on tryptophan metabolism and disposition in the rat", Biochem J, 255, pp.369~372 (1988)
4. Badawy AA, "Animal liver tryptophan pyrrolases:absence of apoenzyme and of hormonal induction mechanism from species sensitive to tryptophan toxicity", Biochem J, 158, pp.79~88 (1976)
5. Pfefferkorn ER, "Characterization of an indoleamine 2,3-dioxygenase induced by gammainterferon in cultured human fibroblasts", J Interferon Res, 6, pp.267~279 (1986)
6. Werner ER, "Human macrophages degrade tryptophan upon induction by interferon-gamma", Life Sci, 41, pp.273~280 (1987)
7. Ozaki Y, "The actions of interferon and antiinflammatory agents on induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes", Biochem Biophys Res Commun, 144, pp.1147~1153 (1987)
8. Badawy AA, "Tryptophan: the key to boosting brain serotonin synthesis in depressive illness", J Psychopharmacol, 27, pp.878~893 (2013)
9. Taylor MW, "Relationship between interferongamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism", FASEB J, 5, pp.2516~2522 (1991)
10. Daubener W, "IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism", Adv Exp Med Biol, 467, pp.517~524 (1999)
11. Yamazaki F, "Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme", Biochem J, 230, pp.635~638 (1985)
12. Yoshiki Kudo, "The role of placental indoleamine 2,3-dioxygenase in human pregnancy", Obstetrics & Gynecology Science, 56(04), pp.209~216 (2013), 대한산부인과학회
13. Munn DH, "Prevention of allogeneic fetal rejection by tryptophan catabolism", Science, 281, pp.1191~1193 (1998)
14. De Antoni A, "Total and free tryptophan levels in serum of newborn infants: relationships with the serotonin and nicotinic acid pathways", Acta Vitaminol Enzymol, 2, pp.17~20 (1980)
15. Handley SL, "Tryptophan, cortisol and puerperal mood", Br J Psychiatry, 136, pp.498~508 (1980)
16. Morita I, "Difference in the concentration of tryptophan metabolites between maternal and umbilical foetal blood", J Chromatogr, 576, pp.334~339 (1992)
17. Schrocksnadel H, "Decreased plasma tryptophan in pregnancy", Obstet Gynecol, 88, pp.47~50 (1996)
18. Abou-Saleh MT, "Postpartum mood changes and plasma amino-acids", Curr Psychiatry, 5, pp.314~319 (1998)
19. Maes M, "Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to deliveryinduced immune activation and early post-partum anxiety and depression", Psychol Med, 31, pp.847~858 (2001)
20. Wachter H, "Neopterin as marker for activation of cellular immunity:immunologic basis and clinical application", Adv Clin Chem, 27, pp.81~141 (1989)
21. Werner ER, "Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells. GTP-cyclohydrolase I is stimulated by interferon-gamma, and 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present", J Biol Chem, 265, pp.3189~3192 (1990)
22. Badawy AA, "Plasma free tryptophan revisited: what you need to know and do before measuring it", J Psychopharmacol, 24, pp.809~815 (2010)
23. Sherlock S, "Diseases of the liver and biliary system", pp.400~405 (1981), Blackwell
24. Herrera E, "Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus", Eur J Clin Nutr, 54(Suppl 1), pp.S47~S51 (2000)
25. Abbassi-Ghanavati M, "Pregnancy and laboratory studies: a reference table for clinicians", Obstet Gynecol, 114, pp.1326~1331 (2009)
26. Laron Z, "Growth hormone, glucose, and free fatty acid levels in mother and infant in normal, diabetic and toxaemic pregnancies", Arch Dis Child, 42, pp.24~28 (1967)
27. Chen X, "Association of elevated free fatty acids during late pregnancy with preterm delivery", Obstet Gynecol, 112(2 Pt 1), pp.297~303 (2008)
28. El Beltagy NS, "Can serum free fatty acids assessment predict severe preeclampsia?", Alexandria J Med, 47, pp.277~281 (2011)
29. Altman K, "Correlation of kynurenine excretion with liver tryptophan pyrrolase levels in disease and after hydrocortisone induction", J Clin Invest, 45, pp.1527~1534 (1966)
30. Protein and amino acid requirements in human nutrition: report of a joint WHO, "FAO", UNU expert consultation, World Health Organisation, pp.2007, ~
31. Moe AJ, "Placental amino acid transport", Am J Physiol, 268(6 Pt 1), pp.C1321~C1331 (1995)
32. Carretti N, "Serum tryptophan and 5-hydroxytryptophan at birth and during post-partum days", Adv Exp Med Biol, 527, pp.757~760 (2003)
33. Moniz CF, "Normal reference ranges for biochemical substances relating to renal, hepatic, and bone function in fetal and maternal plasma throughout pregnancy", J Clin Pathol, 38, pp.468~472 (1985)
34. Tsuji A, "L-tryptophan metabolism in pregnant mice fed a high L-tryptophan diet and the effect on maternal, placental, and fetal growth", Int J Tryptophan Res, 6, pp.21~33 (2013)
35. Hiratsuka C, "Supplementing healthy women with up to 5.0 g", d of L-tryptophan has no adverse effects, 2013, pp.143, 859~866
36. Moffett JR, "Tryptophan and the immune response", Immunol Cell Biol, 81, pp.247~265 (2003)
37. Mellor AL, "Tryptophan catabolism and T cell responses", Adv Exp Med Biol, 527, pp.27~35 (2003)
38. Schrocksnadel K, "Tryptophan degradation during and after gestation", Adv Exp Med Biol, 527, pp.77~83 (2003)
39. Werner ER, "Tryptophan degradation in patients infected by human immunodeficiency virus", Biol Chem Hoppe Seyler, 369, pp.337~340 (1988)
40. Fuchs D, "Immune activation and decreased tryptophan in patients with HIV-1 infection", J Interferon Res, 10, pp.599~603 (1990)
41. Takikawa O, "Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase", J Biol Chem, 261, pp.3648~3653 (1986)
42. Kolodziej LR, "Kynurenine metabolism in health and disease", Amino Acids, 41, pp.1173~1183 (2011)
43. Kudo Y, "The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants", J Physiol, 531(Pt 2), pp.417~423 (2001)
44. Vumma R, "Tryptophan transport in human fibroblast cells-a functional characterization", Int J Tryptophan Res, 4, pp.19~27 (2011)
45. -DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase, "Arch Biochem Biophys", 1991, 326~333
46. Iizuka H, "Fluorometric determination of L-kynurenine with glycolaldehyde by high performance liquid chromatography", Adv Exp Med Biol, 398, pp.749~753 (1996)
47. Garber K, "Evading immunity: new enzyme implicated in cancer", J Natl Cancer Inst, 104, pp.349~352 (2012)
48. Kiank C, "Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans", PLoS One, 5, pp.e11825~ (2010)
49. Monroe CB, "Induction of tryptophan oxygenase and tyrosine aminotransferase in mice", Am J Physiol, 214, pp.1410~1414 (1968)
50. Badawy AA, "The role of free serum tryptophan in the biphasic effect of acute ethanol administration on the concentrations of rat brain tryptophan, 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid", Biochem J, 160, pp.315~324 (1976)
51. Badawy AA, "Liver tryptophan pyrrolase. A major determinant of the lower brain 5-hydroxytryptamine concentration in alcohol-preferring C57BL mice", Biochem J, 264, pp.597~599 (1989)
52. Bano S, "Tryptophan metabolism in relation to mental illness", pp.1997
53. O’Connor MA, "The role of indoleamine 2,3-dioxygenase in LP-BPM5 murine retroviral disease progression", Virol J, 10, pp.154~ (2013)
54. Carrera-Silva EA, "TLR2, TLR4 and TLR9 are differentially modulated in liver lethally injured from BALB", c and C57BL, Mol Immunol, pp.2008, 45[DOI]
55. Soudi S, "Comparative study of the effect of LPS on the function of BALB", c and C57BL, Cell J, pp.2013, 15[DOI]
56. Bernardi F, "Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia", J Obstet Gynaecol Res, 34, pp.948~951 (2008)
57. Sacks GP, "Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis", Am J Obstet Gynecol, 179, pp.80~86 (1998)
58. Szarka A, "Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array", BMC Immunol, 11, pp.59~ (2010)
59. Borzychowski AM, "Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells", Eur J Immunol, 35, pp.3054~3063 (2005)
60. Cayci T, "Cord blood and maternal serum neopterin concentrations in patients with pre-eclampsia", Clin Chem Lab Med, 48, pp.1127~1131 (2010)
61. Nilsen RM, "Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia", Obstet Gynecol, 119, pp.1243~1250 (2012)
62. Taniguchi K, "Serotonin metabolism in the fetus in preeclampsia", Asia Oceania J Obstet Gynaecol, 20, pp.77~86 (1994)
63. Oian P, "Increased arterial catecholamines in pre-eclampsia", Acta Obstet Gynecol Scand, 65, pp.613~617 (1986)
64. Manyonda IT, "A role for noradrenaline in pre-eclampsia: towards a unifying hypothesis for the pathophysiology", Br J Obstet Gynaecol, 105, pp.641~648 (1998)
65. Endresen MJ, "Increased lipolytic activity of sera from pre-eclamptic women due to the presence of a lysophospholipase", Scand J Clin Lab Invest, 53, pp.733~739 (1993)
66. Badawy AA, "Regulation of rat liver tryptophan pyrrolase by its cofactor haem: experiments with haematin and 5-aminolaevulinate and comparison with the substrate and hormonal mechanisms", Biochem J, 150, pp.511~520 (1975)
67. Gal EM, "Tryptophan loading:consequent effects on the synthesis of kynurenine and 5-hydroxyindoles in rat brain", J Neurochem, 31, pp.237~244 (1978)
68. Evans RW, "Maternal and fetal amino acid concentrations and fetal outcomes during pre-eclampsia", Reproduction, 125, pp.785~790 (2003)
69. Moiseiwitsch JR, "The role of serotonin and neurotransmitters during craniofacial development", Crit Rev Oral Biol Med, 11, pp.230~239 (2000)
70. Cordeaux Y, "Characterization of serotonin receptors in pregnant human myometrium", J Pharmacol Exp Ther, 328, pp.682~691 (2009)
71. Cote F, "Maternal serotonin is crucial for murine embryonic development", Proc Natl Acad Sci U S A, 104, pp.329~334 (2007)
72. Bonnin A, "Placental source for 5-HT that tunes fetal brain development", Neuropsychopharmacology, 37, pp.299~300 (2012)
73. Stone TW, "Neuropharmacology of quinolinic and kynurenic acids", Pharmacol Rev, 45, pp.309~379 (1993)
74. Von Bubnoff D, "FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses", J Immunol, 169, pp.1810~1816 (2002)
75. Badawy AA, "Rapid isocratic liquid chromatographic separation and quantification of tryptophan and six kynurenine metabolites in biological samples with ultraviolet and fluorimetric detection", Int J Tryptophan Res, 3, pp.175~186 (2010)

관련 논문AI추천